Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

P. Dearnaley, David; Jovic, Gordana; Syndikus, Isabel; Khoo, Vincent; Cowan, Richard; D. Graham, John; Aird, Edwin; Bottomley, David; Huddart, Robert; Jose, Chakiath; H. Matthews, J.; Millar, Jeremy; Murphy, Claire; M. Russell, John; Scrase, Christopher; Parmar, Mahesh; R. Sydes, Matthew

doi:10.1016/s1470-2045(14)70040-3

Public

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

Published in The Lancet Oncology • Feb 26, 2014

Authors:

David P. Dearnaley

Gordana Jovic

Isabel Syndikus

Abstract

BACKGROUND: The aim of this trial was to compare dose-escalated conformal radiotherapy with control-dose conformal radiotherapy in patients with localised prostate cancer. Preliminary findings reported after 5 years of follow-up showed that escalated-dose conformal radiotherapy improved biochemical ...

Subject

Medicine

Radiation therapy

Prostate cancer

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!